Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer
Clinical trial NCT01844817 · COMPLETED
Trial details
- NCT number
- NCT01844817
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.